REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
56,097,077
Share change
+86,979
Total reported value
$7,068,554,308
Put/Call ratio
21%
Price per share
$126.06
Number of holders
445
Value change
-$93,174,903
Number of buys
218
Number of sells
247

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2024

As of 30 Jun 2024, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 445 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,097,077 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, Invesco Ltd., BROWN CAPITAL MANAGEMENT LLC, and MACQUARIE GROUP LTD. This page lists 443 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.